340B Impact on the Federal Budget – Authored by Former CBO Director Dan Crippen

This memo summarizes the creation and subsequent explosive growth of the 340B Drug
Pricing Program and explores the likely federal and state budgetary effects of legislation
that requires pharmaceutical manufacturers to subsidize drug purchases by certain
healthcare providers.